$24.68
2.68[12.18%]
Last update: 6:24AM Get Real Time Here
Addex Therapeutics
(NASDAQ:ADXN)Addex Therapeutics Stock (NASDAQ:ADXN), Analyst Ratings, Price Targets, Predictions
Addex Therapeutics Ltd has a consensus price target of $0, established from looking at the 4 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on June 23, 2022, May 31, 2022, and February 11, 2022. With an average price target of $12 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied -48.28% downside for Addex Therapeutics Ltd from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Addex Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 06/23/2022 | ADXN | Buy Now | Addex Therapeutics | $23.20 | — | HC Wainwright & Co. | Raghuram Selvaraju | — | Downgrade | Buy → Neutral | Get Alert |
| 05/31/2022 | ADXN | Buy Now | Addex Therapeutics | $23.20 | -35.34% | HC Wainwright & Co. | Raghuram Selvaraju | $420 → $300 | Maintains | Buy | Get Alert |
| 02/11/2022 | ADXN | Buy Now | Addex Therapeutics | $23.20 | -9.48% | HC Wainwright & Co. | Raghuram Selvaraju | $560 → $420 | Maintains | Buy | Get Alert |
| 04/21/2021 | ADXN | Buy Now | Addex Therapeutics | $23.20 | 20.69% | HC Wainwright & Co. | Raghuram Selvaraju | → $560 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Addex Therapeutics (ADXN)?
The latest price target for Addex Therapeutics (NASDAQ: ADXN) was reported by HC Wainwright & Co. on June 23, 2022. The analyst firm set a price target for $0.00 expecting ADXN to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Addex Therapeutics (ADXN)?
The latest analyst rating for Addex Therapeutics (NASDAQ: ADXN) was provided by HC Wainwright & Co., and Addex Therapeutics downgraded their neutral rating.
When was the last upgrade for Addex Therapeutics (ADXN)?
There is no last upgrade for Addex Therapeutics.
When was the last downgrade for Addex Therapeutics (ADXN)?
The last downgrade for Addex Therapeutics Ltd happened on June 23, 2022 when HC Wainwright & Co. changed their price target from N/A to N/A for Addex Therapeutics Ltd.
When is the next analyst rating going to be posted or updated for Addex Therapeutics (ADXN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Addex Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Addex Therapeutics was filed on June 23, 2022 so you should expect the next rating to be made available sometime around June 23, 2023.
Is the Analyst Rating Addex Therapeutics (ADXN) correct?
While ratings are subjective and will change, the latest Addex Therapeutics (ADXN) rating was a downgraded with a price target of $0.00 to $0.00. The current price Addex Therapeutics (ADXN) is trading at is $24.68, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.